日本語View as Markdown

Novel therapeutic approaches based on the pathological role of gut dysbiosis on the link between nonalcoholic fatty liver disease and insulin resistance.

腸内細菌叢の乱れと非アルコール性脂肪肝疾患・インスリン抵抗性の関連に基づく新たなアプローチ:レビュー

review hydrogen-rich water not assessed

Abstract

The global rise in obesity and type 2 diabetes has driven a parallel increase in the prevalence of nonalcoholic fatty liver disease (NAFLD), now recognized as the most frequent chronic liver condition in Western populations and a major indication for liver transplantation. This review synthesizes evidence from both animal and human studies demonstrating tight interconnections among insulin resistance, gut dysbiosis, and hepatic steatosis. The pathological cascade leading to increased intestinal permeability, hepatic inflammation, and fibrosis remains incompletely understood. A literature search across multidisciplinary databases was conducted using terms including 'NAFLD', 'gut dysbiosis', 'insulin resistance', 'inflammation', 'probiotics', and 'Chinese herbs'. Findings indicate that diverse interventions—probiotics, prebiotics, synbiotics, postbiotics, fecal microbiota transplantation, Chinese herbal medicine, antibiotics, polyphenol-rich and fasting diets, carbon nanoparticles, MCJ protein modulation, and molecular hydrogen-rich water—may favorably modify the NAFLD phenotype. The review provides a comprehensive framework for understanding how dysbiosis and insulin resistance jointly drive NAFLD progression and highlights current investigational strategies.

Mechanism

Gut dysbiosis exacerbates insulin resistance and increases intestinal permeability, allowing translocation of microbial products that trigger hepatic inflammatory signaling and lipid accumulation, thereby promoting NAFLD progression. Molecular hydrogen-rich water is noted as one of several adjunctive approaches that may attenuate this phenotype.

Bibliographic

Authors
Bellucci E, Chiereghin F, Pacifici F, Donadel G, De Stefano A, Malatesta G, et al.
Journal
Eur Rev Med Pharmacol Sci
Year
2023
PMID
36930488
DOI
10.26355/eurrev_202303_31558

Tags

Disease:糖尿病・代謝症候群 腸管障害 肝疾患 Delivery:水素水経口投与 Mechanism:免疫調節 炎症抑制 酸化ストレス

Delivery context

Hydrogen-rich water is a low-risk delivery route, but the achievable systemic hydrogen dose is bounded. For clinical applications, inhalation is the most efficient route; inhalation, however, carries explosion risk, and concentration matters (empirical LFL of 10% applies to inhalation environments; high-concentration devices are documented in the Consumer Affairs Agency accident database and are not recommended).

Safety notes

Hydrogen-rich water is a low-risk delivery route, but the achievable systemic hydrogen dose is bounded. For clinical applications, inhalation is the most efficient route; inhalation, however, carries explosion risk, and concentration matters (empirical LFL of 10% applies to inhalation environments; high-concentration devices are documented in the Consumer Affairs Agency accident database and are not recommended).

See also:

Other papers on the same disease / condition

Cite as: H2 Papers — PMID 36930488. https://h2-papers.org/en/papers/36930488
Source: PubMed PMID 36930488